13:55 IST
BSE
Management Change
Bharat Parenterals Management Change
Bharat Parenterals Limited has re-appointed Mr. Hemang Jayendrabhai Shah as Executive Director for a 5-year term effective July 2, 2026.
Bharat Parenterals Ltd
- Share price
- ₹1,879.15
- Market cap
- ₹1,295 Cr
- Revenue (annual)
- ₹345.4 Cr
- Net profit (annual)
- ₹-8.19 Cr
- P/E (TTM)
- -84.1×Sector 47.4×
- Promoter holding
- 67.20%+0.03% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Earnings Call 4Promoter Buying 3Other Announcement 3Management Change 3Board Meeting Date 3Annual General Meeting 2Price Movement Clarification 1Dividend 1Debt & Borrowing 1Capacity Expansion 1Business Update 1Annual Report 1
Time
3 announcements with these filters
17:57 IST
BSE
Management Change
Bharat Parenterals Management Change
Bharat Parenterals Ltd re-appointed Mr. Hemang Shah as Executive Director for a five-year term. The appointment is subject to shareholder approval at the ensuing AGM.
17:26 IST
BSE
Management Change
Bharat Parenterals Management Change
Bharat Parenterals re-appointed its Cost and Internal Auditors for the 2026-27 financial year. Both firms possess over 16 years of experience, ensuring continued regulatory compliance.
- Execution
- Financial year 2026-27